Skip to main content
Monthly Archives

February 2022

Forbes interviews the women in leadership driving ProteX and Reproductive Solutions. Diana Peninger CEO of Reproductive Solutions with ProteX Semen Sample Collection ContainerFeatured ArticlesForbes

Forbes interviews the women in leadership driving ProteX and Reproductive Solutions.

@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9kYXRlIiwic2V0dGluZ3MiOnsiYmVmb3JlIjoiIiwiYWZ0ZXIiOiIiLCJkYXRlX2Zvcm1hdCI6IkYgZCwgWSIsImN1c3RvbV9kYXRlX2Zvcm1hdCI6IiJ9fQ==@ForbesWomen profiles the female leadership at Reproductive Solutions and Texas Tech University who have truly…
February 11, 2022

Reproductive Solutions

Privacy Policy & Terms of Use

All ProteX claims of improved semen quality are made comparing collection in ProteX to collection in a standard specimen cup, and are based on published study data. Results using ProteX will vary by each patient and are affected by a number of uncontrolled factors, including and not limited to the patient’s age, diagnosis, lifestyle, diet, and genetics. Reproductive Solutions makes no guarantee of pregnancy outcomes when using ProteX. ProteX is a registered trademark of Reproductive Solutions.

Patent US 6,864,046 B1, Patent: US 17/364,792, PCT/US2021/040017 Ctrl# PTX-MMTL-20044 rev. 00

© 2024 Reproductive Solutions.